Meredith Faggen

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

December, 2024

Meredith Faggen

Jul 29, 2024, 11:19 | Insight

Rasha Aboelhassan: We can give TDM1 in stage I HER2 positive breast cancer

Rasha Aboelhassan shared a post on LinkedIn about a recent paper by Paolo Tarantino et al., commenting:…

Jul 25, 2024, 20:48 | Insight

Subcutaneous vs Intravenous Trastuzumab/Pertuzumab in HER2+ Breast Cancer

Dana-Farber’s Breast Oncology Center shared on X: "New in JCO Oncology Practice: Subcutaneous vs Intravenous…

Jul 20, 2024, 11:01 | Insight

Paolo Tarantino: Thanks to ESMO for featuring our 5-year analysis of the ATEMPT randomized phase 3 trial

Paolo Tarantino shared a post on LinkedIn about a paper titled "Adjuvant Trastuzumab Emtansine Versus…

Jul 5, 2024, 06:54 | Blog

Paolo Tarantino: Nearly 1000 downloads in less than a week for our ATEMPT 5-year publication

Paolo Tarantino, posted on X: "Nearly 1000 downloads in less than a week for our…

Jul 1, 2024, 15:23 | Insight

Paolo Tarantino: Final analysis of the ATEMPT phase 2 trial

Paolo Tarantino shared a post on X: “Can ADCs help prevent recurrence from breast cancer…

All: 5 Posts: 1 - 100

'

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

'

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

'

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

'

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

'

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023